Raven Health and Flychain Announce Strategic Partnership to Revolutionize Financial Operations for ABA Therapy Providers
Slice of Healthcare Team
09/19/2024
Key Highlights
- Partnership streamlines revenue cycle management for ABA therapy providers.
- Flychain’s financial tools offer real-time insights, secure funding, and automation.
- Raven Health’s clinical solutions integrate with Flychain’s expertise for full-service support.
- Focus on reducing financial pressures for new and growing ABA clinics.
Source: Business Wire
Notable Quotes
“ This partnership with Flychain represents a significant step forward in our mission to support ABA therapy providers. ”
Richard Wagner, CEO at Raven Health
“ Together, we streamline both clinical and financial workflows, empowering healthcare providers to focus more on patient care while optimizing their financial health. ”
Ethan Schwarzbach, CEO & Co-Founder at Flychain
SoHC's Take
This partnership between Raven Health and Flychain is a pivotal move for ABA therapy providers, particularly for small and growing clinics. By combining Raven’s cutting-edge clinical management software with Flychain’s robust financial solutions, this collaboration addresses two critical areas: efficient clinical workflows and optimized financial health. The integration of financial tools such as accurate reporting, funding access, and RCM enhancements will empower ABA providers to scale effectively while maintaining focus on delivering quality care. This strategic alliance could set a new standard for how healthcare providers manage both their clinical and financial operations.
Heading
Ginkgo Bioworks Launches Protein LLM and Model API Powered by Google Cloud News Product News Read More Chris-Anne Roque Raven Health and Flychain Announce Strategic Partnership to Revolutionize Financial Operations for ABA Therapy Providers News Partnership News Read More Chris-Anne Roque Nura Bio Secures $140M in Series A Financing and Appoints Shilpa Sambashivan, Ph.D., as CEO Funding News News Read More Chris-Anne Roque Peer-Reviewed Research Shows CGM Benefits Through Medical Over Pharmacy Clinical News News Read More Chris-Anne Roque Mirador Therapeutics Appoints Gregg Gilbert as CFO to Drive Growth Hiring News News Read More Chris-Anne Roque Entact Bio Appoints Ruben Tommasi, Ph.D., as Chief Scientific Officer Hiring News News Read More Chris-Anne Roque
